Search by Topic
Join our mailing list!
Thanks! You've been successfully signed up for the BTU newsletter!
BLACK-FIRE* Nitrile Exam Gloves
The new BLACK-FIRE* Nitrile Exam Glove helps protect you when working with patients, when you need to direct traffic – it can even alert you when there’s a dangerous rip or tear.
Recertified Lifepak 12 12-Lead Biphasic Defibrillators
The Lifepak 12 Defibrillator/Monitor is a multi-parameter device that combines semi-automated and manual defibrillation with capnography, external pacing, 12-lead electrocardiography and other monitoring functions.
Medi-Trace Foam Electrodes
All Medi-Trace electrodes have a high quality foam substrate that conforms easily to the skin to ensure electrical contact for consistent tracings.
November 11, 2015
Continuous chest compressions vs. CPR for cardiac arrest: 3 takeaways
Since Sudden Cardiac Arrest (SCA) continues to be a major cause of death in the U.S., it makes sense that research that has been ongoing for more than 60 years should remain hot and heavy. The history of resuscitation can be traced by the treatments we provided.
Most of us will not remember when closed chest compressions, proposed by Dr. James Jude and colleagues, were a novelty, a research project that mandated further study. EMS dinosaurs will remember when CPR rates were 60 compressions per minute. Then rates increases to 80 beats per minute. And two-person ratios for CPR were 5 compressions for each ventilation given to the patient.
Sadly, over the second half of the 20th century most resuscitation efforts focused on the advanced portion of resuscitation — drugs, advanced airways and invasive procedures. Hindsight being 20/20, it is likely the resuscitation profession lost real progress by not focusing on the basics of ventilation and perfusion.
In the 1990s research began validating the effectiveness of high-quality chest compressions and prompt defibrillation. A Resuscitation Outcomes Consortium study comparing continuous chest compression and standard CPR, published this week in the New England Journal of Medicine, continues the tradition of looking for the next best resuscitation mousetrap.
Here are three key points to take away from this effort:
1. The number of patients enrolled is huge. Twenty-five thousand patients spread over large areas of the country make the results much less vulnerable to simple chance findings.
2. A prospective research design was used which means the researchers attempted to control for a variety of factors that could have affected the outcomes.
3. The authors point out that they could not control for what happened to the patients after EMS transferred the patient to the next level of care. Reaffirming that EMS is just one link in the resuscitation chain of survival. It's critical that all parts of that chain function well in order to give the patient the best chance for surviving neurologically intact. EMS can have a significant impact by delivering a viable patient to the next level of care.
We are moving into an era in which increasing cardiac arrest survival rates will be based on incremental fine tuning of effective procedures and techniques. We need to continue working with our lifesaving partners, bystanders and intensivists alike, to help reverse this major killer.
What are your key takeaways? Share your thoughts with other professionals in the comments.